Terran Biosciences announces publication of four PCT patent applications covering breakthroughs...

GH Research Reports First Quarter 2023 Financial Results and Provides Business...

COMPASS Pathways Announces First Quarter 2023 Financial Results and Business Highlights

Brain scanning technology to be used for clinical psychedelics trials in...

Sunstone Therapies to present data on the long-term efficacy of psilocybin...

atai Life Sciences Reports First Quarter 2023 Financial Results and Announces...

MIND CURE CLOSES PREVIOUSLY ANNOUNCED PRIVATE PLACEMENT

Optimi Health Granted Natural Health Product Site Licence By Health Canada

Clearmind Medicine Retains Crescendo Communications LLC. for Investor Relations and Announces...

PT409 – Pathology, the DSM, and the Ontological Shock of Psychedelic...

Load more